1. New Products

New Products

Cat. No. Product Name Target Research Area Added Chemical Structure
HY-N0472 Geraniin

TNF Receptor

Cancer;

Inflammation/Immunology;

Metabolic Disease

2018-11 Geraniin
HY-113212 Ursocholic acid

Endogenous Metabolite

Metabolic Disease

2018-11 Ursocholic acid
HY-16743A Ibiglustat succinate

Others

Metabolic Disease

2018-11 Ibiglustat succinate
HY-16780 Gemilukast

Leukotriene Receptor

Inflammation/Immunology

2018-11 Gemilukast
HY-P1477A Adrenocorticotropic Hormone (ACTH) (1-39), rat TFA

Others

Metabolic Disease

2018-11 Adrenocorticotropic Hormone (ACTH) (1-39), rat TFA
HY-U00428A GNE 220 Hydrochloride

MAP4K

Cancer

2018-11 GNE 220 Hydrochloride
HY-114117 Tyclopyrazoflor

Others

Others

2018-11 Tyclopyrazoflor
HY-N0794 Proanthocyanidins

Others

Cardiovascular Disease

2018-11 Proanthocyanidins
HY-112921 diABZI STING agonist-1

STING

Inflammation/Immunology

2018-11 diABZI STING agonist-1
HY-19654 GSK598809

Dopamine Receptor

Neurological Disease

2018-11 GSK598809
HY-16011 NE 10790

Others

Others

2018-11 NE 10790
HY-13255A TAME hydrochloride

APC

Cancer

2018-11 TAME hydrochloride
HY-101565 AMG-176

Bcl-2 Family

Cancer

2018-11 AMG-176
HY-N0319 Salvianolic acid C

Cytochrome P450

Cancer

2018-11 Salvianolic acid C
HY-101540 NMI 8739

Dopamine Receptor

Neurological Disease

2018-11 NMI 8739
HY-107430 Oxythiamine

Others

Cancer

2018-11 Oxythiamine
HY-13914 Roniciclib

CDK

Cancer

2018-11 Roniciclib
HY-112861 Gln-AMS

Aminoacyl-tRNA Synthetase

Others

2018-11 Gln-AMS
HY-109059 Fulacimstat

Others

Cardiovascular Disease

2018-11 Fulacimstat
HY-12685 Ceralifimod

LPL Receptor

Neurological Disease

2018-11 Ceralifimod